Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTasty Regulatory News (TAST)

  • There is currently no data for TAST

Placing

7 Nov 2016 14:37

RNS Number : 5243O
Tasty PLC
07 November 2016
 

7 November 2016

 

Tasty Plc ("Tasty" or the "Company")

 

Placing and Director/PDMR Shareholdings

 

The Company today announces that it has conditionally raised £9.0 million, before expenses, through a placing of 6,210,000 new Ordinary Shares ("New Shares") at a price of 145 pence per share (the "Placing Price") (the "Placing"). The Placing Price is at zero discount to the closing middle market price of the Company on 4 November 2016 (being the latest practicable date prior to this announcement). The Directors are pleased to confirm that the Placing was over-subscribed and supported by both new and existing institutional investors, as well as the Board.

 

The net proceeds from the Placing will be used by the Company to fund the continued expansion of the Company's restaurants estate. The directors of the Company are pleased to confirm that current trading remains in line with expectations and that the continued roll out of the Wildwood restaurant brand is proceeding well.

 

The Placing

 

As set out above, the Company has conditionally raised approximately £9.0 million before expenses by the conditional Placing of 6,210,000 New Shares at the Placing Price. The New Shares represent approximately 11.6 per cent. of the current issued share capital of the Company.

The Placing is conditional, inter alia, upon:

(a) the passing of the Resolutions at the General Meeting (as described below);

(b) the Placing Agreement becoming or being declared unconditional in all respects and not having been terminated in accordance with its terms prior to Admission;

(c) Admission becoming effective by no later than 8.00 a.m. on 2 December 2016 or such later time and/or date (being no later than 8.00 a.m. on 31 December 2016) as Cenkos Securities plc and the Company may agree.

If any of the conditions are not satisfied, the Placing Shares will not be issued and all monies received from the Placees will be returned to the Placees (at the Placees' risk and without interest) as soon as possible thereafter.

The Placing Shares are not subject to clawback. The Placing is not being underwritten.

The Placing Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

Director Dealings

 

As part of the Placing certain directors of the Company, or members of their immediate family, have agreed to subscribe for New Shares at the Placing Price as set out below:

 

Name

Title

No. of New Shares subscribed for under the Placing

Samuel Kaye

Joint Chief Executive

1,060,349

Jonny Plant

Joint Chief Executive

68,966

Keith Lassman

Chairman

13,793

 

In addition to the above Adam Kaye, a Non-Executive Director of the Company, or members of his immediate family have agreed to subscribe for 517,241 New Shares. Adam Kaye has also exercised his right to exchange 500,000 'A' ordinary shares in a subsidiary company of the Company into Ordinary Shares (the "Share Incentive"). The number of Ordinary Shares being acquired is equal in value to the net benefit that would be delivered to Adam Kaye if the Share Incentive were provided by way of a share option over Ordinary Shares at an exercise price of 100 pence per Ordinary Share (i.e. the value above 100 pence per Ordinary Share). Adam Kaye will therefore receive 155,172 Ordinary Shares following the exercise of the Share Incentive. Adam Kaye has entered into an agreement to sell the 155,172 Ordinary Shares issued to him following the exercise of the Share Incentive and also to sell a further 1,220,920 Ordinary Shares held by him, conditional on admission of the New Shares (the "Share Sale"). The net effect of these arrangements on Adam Kaye's beneficial and non-beneficial holding once the Placing completes will be a decrease of 703,679 Ordinary Shares.

 

Following the above events and conditional on admission of the New Shares the Directors will be interested in the following number of Ordinary Shares in the Company:

 

Name

Title

No. Ordinary Shares held following the Placing, the exercise of the Share Incentive and the Share Sale

% of the issued share capital of the Company as enlarged by the Placing and the exercise of the Share Incentive

Jonny Plant

Joint Chief Executive

4,263,843

7.14%

Samuel Kaye

Joint Chief Executive

10,750,589

18.00%

Adam Kaye

Non-Executive Director

7,236,559

12.12%

Keith Lassman

Chairman

148,433

0.25%

The participation in the Placing by Samuel Kaye and Adam Kaye (as directors and substantial shareholders of the Company) and of Livingbridge VC LLP (or funds managed by Livingbridge VC LLP) (as a substantial shareholder) constitute related party transactions pursuant to the AIM Rules. Livingbridge VC LLP currently has an interest in 7,684,648 Ordinary Shares of the Company representing 14.40 of the current issued share capital of the Company. Livingbridge VC LLP are subscribing for 1,017,000 New Shares as part of the Placing.

 

The Directors (excluding Samuel Kaye and Adam Kaye) consider, having consulted with Cenkos Securities plc, the Company's Nominated Adviser for the purposes of the AIM Rules, that the terms of the related party subscriptions for New Shares as set out above are fair and reasonable insofar as the shareholders of the Company are concerned.

Admission

Application will be made to the London Stock Exchange for the admission of the New Shares to trading on AIM. It is expected that Admission to trading on AIM will occur and that dealings will commence at 8.00 a.m. on 2 December 2016 at which time it is also expected that the New Shares will be enabled for settlement in CREST.

Application will also be made to the London Stock Exchange for the admission of the 155,172 new Ordinary Shares to be issued following the exercise of the Share Incentive. It is expected that Admission to trading on AIM will occur and that dealings will commence at 8.00 a.m. on 2 December 2016 at which time it is also expected that the 155,172 new Ordinary Shares will be enabled for settlement in CREST.

General Meeting

The Directors do not currently have authority to allot all of the New Shares and, accordingly, the Board is seeking the approval of Shareholders to allot the New Shares at the General Meeting.

A notice convening the General Meeting, which is to be held at the offices of the Company at 3 Heath Street, Hampstead, London, NW3 6TP on 1 December 2016 is set out at the end of a circular to be sent to Shareholders shortly.

Recommendation

 

The Directors consider the Placing to be in the best interests of the Company and the Shareholders as a whole and, accordingly, unanimously recommend that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting as they intend to do in respect of their own beneficial holdings, amounting to 41.2 per cent. of the Company's issued share capital.

 

The Placing is conditional, inter alia, upon the passing of the Resolutions at the General Meeting. Shareholders should be aware that if the Resolutions are not approved at the General Meeting, the conditional Placing will not proceed. The Share Sale is conditional on the passing of the Resolutions at the General Meeting and on the Admission of the New Shares. Shareholders should be aware that if the Resolutions are not approved at the General Meeting, the Share Sale will not proceed.

 

Capitalised terms used in this announcement have the meanings given to them in the Circular, to be posted to Shareholders on or around 8 November 2016.

 

7 November 2016

 

The announcement contains inside information

Enquiries

Tasty plc

Jonny Plant Tel: 020 7637 1166

Cenkos Securities plc - NOMAD and Broker

Bobbie Hilliam Tel: 020 7397 8900

Alex Aylen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBSBDBUXGBGLR
Date   Source Headline
9th Sep 20252:42 pmRNSChange of Name
4th Sep 20254:54 pmRNSHolding(s) in Company
4th Sep 20253:37 pmRNSHolding(s) in Company
4th Sep 202512:17 pmRNSHolding(s) in Company
3rd Sep 202512:00 pmRNSResult of General Meeting and Board Changes
6th Aug 20252:22 pmRNSResult of Retail Offer, Revised Timetable & TVR
4th Aug 20257:00 amRNSResult of Placing and Subscription
1st Aug 20254:35 pmRNSRetail Offer
1st Aug 20254:30 pmRNSProposed Fundraising
28th Jul 202511:27 amRNSResponse to Press Speculation
25th Jun 20256:17 pmRNSHolding(s) in Company
19th Jun 20252:04 pmRNSResult of AGM
7th May 20257:00 amRNSFinal Results
13th Feb 20259:30 amRNSHolding(s) in Company
24th Jan 20257:00 amRNSTrading Update
2nd Jan 20257:00 amRNSInsurance Settlement and Trading Update
30th Sep 20247:00 amRNSHalf-year Report
29th Jul 20244:44 pmRNSHolding(s) in Company
22nd Jul 20242:54 pmRNSResult of AGM & GM
5th Jul 20245:49 pmRNSHolding(s) in Company
3rd Jul 202412:07 pmRNSDirector/PDMR Shareholding
1st Jul 20244:30 pmRNSShare Authorities, Circular & Notice of GM
28th Jun 20245:30 pmRNSPublication of Annual Report and Notice of AGM
28th Jun 20247:00 amRNSFinal Results
4th Jun 20243:50 pmRNSResult of Sanction Hearing and Restructuring Plan
13th May 202412:30 pmRNSRestructuring Plan - Update
3rd May 20244:00 pmRNSRestructuring Plan - Update
9th Apr 202410:47 amRNSTrading Update, Restructuring Plan and Loan
7th Nov 20239:20 amRNSChange of Nominated Adviser and Broker
27th Sep 20237:00 amRNSHalf-year Report
6th Jun 202312:23 pmRNSResult of AGM
15th May 20233:34 pmRNSPosting of Report & Accounts and Notice of AGM
30th Mar 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
19th Sep 20227:00 amRNSHalf-year Report
1st Jul 20227:00 amRNSTotal Voting Rights
30th Jun 20226:10 pmRNSHolding(s) in Company
28th Jun 20224:30 pmRNSHolding(s) in Company
23rd Jun 20224:10 pmRNSRepayment of Bank Facility
22nd Jun 20227:00 amRNSDirectorate Changes and Conversion of B Shares
11th May 20223:25 pmRNSResult of AGM
14th Apr 20224:30 pmRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20227:00 amRNSFinal Results
8th Mar 20227:00 amRNSTrading Update
4th Jan 20227:00 amRNSTrading Update
27th Sep 20217:00 amRNSHalf-year Report
29th Jun 20217:00 amRNSTrading Update
2nd Jun 202111:33 amRNSHolding(s) in Company
21st May 20211:01 pmRNSOperational Update
19th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.